[Iron metabolism in polycythemia vera].
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001815:Bloodletting; D002066:Busulfan / Q000627:therapeutic use; D003676:Deferoxamine / Q000627:therapeutic use; D005260:Female; D006400:Hematocrit; D006801:Humans; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism*; D007503:Iron Isotopes; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000378:metabolism* / Q000628:therapy; D012711:Serum Albumin, Radio-Iodinated
D000970:Antineoplastic Agents; D007503:Iron Isotopes; D012711:Serum Albumin, Radio-Iodinated; D007501:Iron; D002066:Busulfan; D003676:Deferoxamine
Eisentoffwechseluntersuchungen bei Polyzythämia vera.